Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article


Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
Colorimetric detection of multiplex assays.

SCIENION AG has announced the introduction of its sciREADER CL for colorimetric detection of multiplex assays.

With the sciREADER Scienion extends its product portfolio in order to provide customers with best quality equipment for total multiplexing solutions.

The new sciREADER system is suitable for all kind of multiplex assays in planar array formats such as microtiter plates and slides. Image acquisition and analysis software are optimized for 96-well formats.

The desktop sciREADER version comes with an intuitive software and multiple features, e.g. automated spot finding and evaluation of single arrays or array batches.

It also allows for customization of array analysis and report formats. Ready to use applications include DNA and protein multi-parameter analysis, genotyping and pathogen identification.

Holger Eickhoff, CEO of SCIENION AG, comments: “We are continuously striving to meet the needs of our customers, and adding the new sciREADER to our product portfolio is another module reflecting our strategy to offer total solutions for multiplexing. Fast set-up time and read-out, high resolution digital imaging and efficient data analysis make our sciREADER the ideal instrument for people in life science research, especially in molecular diagnostics.”

sciREADER CL is fully compatible with all microplate formats and optimized for sciPLEXPLATES and the sciFLEXARRAYER technology.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIENION and Greiner Bio-One Enter a Collaboration
Collaboration for the development of rapid diagnostic tests.
Saturday, November 14, 2015
QuantuMDx and SCIENION Partner to Commercialize Novel Nanowire Biosensor
This biosensor is a component of QMDx's flagship product Q-POC™, a handheld molecular diagnostic device that will provide results in 15 minutes for a few pounds at the patient's side.
Tuesday, June 09, 2015
Positive Feedback on Scienion’s Unique Workshop on the IVD Value Chain
“From Sample to Assay – From R&D to IVD” was the title of a two-day workshop Scienion AG hosted in Berlin recently. Almost 100 participants from 12 countries benefited from an outstanding program.
Wednesday, November 03, 2010
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos